Hyperfine (HYPR) Depreciation & Amortization (CF) (2021 - 2026)
Hyperfine's (HYPR) quarterly Depreciation & Amortization (CF) came in at $274000.0 in Q1 2026, up 19.65% YoY from $229000.0 in Q1 2025, and down 2.49% on a QoQ basis from $281000.0 in Q4 2025.
Hyperfine (HYPR) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
Hyperfine (HYPR) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $274000.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 19.65% year-over-year to $274000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 16.41% YoY) and the FY2025 annual result came in at $1.1 million, up 8.03% from the prior year.
- Depreciation & Amortization (CF) declined to $274000.0 in Q1 2026, from $281000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $297000.0 in Q3 2025 to a low of $229000.0 in Q1 2025.
- A 5-year average of $261294.1 and a median of $261000.0 in 2022 frame the typical range for Depreciation & Amortization (CF).
- The widest YoY moves for Depreciation & Amortization (CF): up 163.54% in 2022, down 22.55% in 2022.
- Tracing HYPR's Depreciation & Amortization (CF) over 5 years: stood at $261000.0 in 2022, then climbed by 0.77% to $263000.0 in 2023, then decreased by 11.03% to $234000.0 in 2024, then advanced by 20.09% to $281000.0 in 2025, then decreased by 2.49% to $274000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $274000.0 (Q1 2026), $281000.0 (Q4 2025), and $297000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Hyperfine | 89.83 Mn | 45.06 Mn | 1.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 264,000.00 |
| Jun 30, 2026 | 264,000.00 |
| Mar 31, 2026 | 274,000.00 |
| Mar 31, 2026 | 274,000.00 |
| Dec 31, 2025 | 281,000.00 |
| Dec 31, 2025 | 281,000.00 |
| Sep 30, 2025 | 297,000.00 |
| Sep 30, 2025 | 297,000.00 |
| Jun 30, 2025 | 283,000.00 |
| Jun 30, 2025 | 283,000.00 |
| Mar 31, 2025 | 229,000.00 |
| Mar 31, 2025 | 229,000.00 |
| Dec 31, 2024 | 234,000.00 |
| Dec 31, 2024 | 234,000.00 |
| Sep 30, 2024 | 259,000.00 |
| Sep 30, 2024 | 259,000.00 |
| Jun 30, 2024 | 253,000.00 |
| Jun 30, 2024 | 253,000.00 |
| Mar 31, 2024 | 263,000.00 |
| Mar 31, 2024 | 263,000.00 |